394 related articles for article (PubMed ID: 14535988)
41. In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C.
Kinnman N; Andersson U; Hultcrantz R
Scand J Gastroenterol; 2000 Dec; 35(12):1294-300. PubMed ID: 11199370
[TBL] [Abstract][Full Text] [Related]
42. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2.
Walia B; Wang L; Merlin D; Sitaraman SV
FASEB J; 2003 Nov; 17(14):2130-2. PubMed ID: 14500551
[TBL] [Abstract][Full Text] [Related]
43. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
Stockwell BR; Schreiber SL
Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
[TBL] [Abstract][Full Text] [Related]
44. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
Xu F; Liu C; Zhou D; Zhang L
J Histochem Cytochem; 2016 Mar; 64(3):157-67. PubMed ID: 26747705
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.
Yang L; Roh YS; Song J; Zhang B; Liu C; Loomba R; Seki E
Hepatology; 2014 Feb; 59(2):483-95. PubMed ID: 23996730
[TBL] [Abstract][Full Text] [Related]
46. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
47. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
48. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
49. TGF-beta 1 signaling controls retinal pericyte contractile protein expression.
Sieczkiewicz GJ; Herman IM
Microvasc Res; 2003 Nov; 66(3):190-6. PubMed ID: 14609524
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins.
Kowalewski R; Malkowski A; Sobolewski K; Gacko M
Pathobiology; 2010; 77(1):1-6. PubMed ID: 20185961
[TBL] [Abstract][Full Text] [Related]
51. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
52. [The role of hepatitis C virus core protein on liver fibrogenesis: a study using an in vitro co-culture system].
Shin JY; Yoon SK; Wang JS; Hur W; Ryu JS; Bae SH; Choi JY; Yang JM; Yang SH; Sung YC; Chung KW; Sun HS
Korean J Gastroenterol; 2003 Nov; 42(5):400-8. PubMed ID: 14646577
[TBL] [Abstract][Full Text] [Related]
53. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
[TBL] [Abstract][Full Text] [Related]
54. Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes.
Leiting S; Seidl S; Martinez-Palacian A; Muhl L; Kanse SM
J Biol Chem; 2016 Sep; 291(40):21020-21028. PubMed ID: 27462075
[TBL] [Abstract][Full Text] [Related]
55. TGF-beta signaling, tumor suppression, and acute lymphoblastic leukemia.
Downing JR
N Engl J Med; 2004 Aug; 351(6):528-30. PubMed ID: 15295044
[No Abstract] [Full Text] [Related]
56. Transforming growth factor betas and their receptors in human liver cirrhosis.
Baer HU; Friess H; Abou-Shady M; Berberat P; Zimmermann A; Gold LI; Korc M; Büchler MW
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1031-9. PubMed ID: 9895050
[TBL] [Abstract][Full Text] [Related]
57. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.
Bedossa P; Peltier E; Terris B; Franco D; Poynard T
Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675
[TBL] [Abstract][Full Text] [Related]
59. Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.
Shirasaki T; Honda M; Shimakami T; Murai K; Shiomoto T; Okada H; Takabatake R; Tokumaru A; Sakai Y; Yamashita T; Lemon SM; Murakami S; Kaneko S
Hepatology; 2014 Nov; 60(5):1519-30. PubMed ID: 24962339
[TBL] [Abstract][Full Text] [Related]
60. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]